Status:

RECRUITING

Open Versus Arthroscopic Stabilization of Shoulder Instability With Subcritical Bone Loss: The OASIS Trial

Lead Sponsor:

University of Pittsburgh

Collaborating Sponsors:

Duke University

Conditions:

Shoulder Dislocation

Glenohumeral Dislocation

Eligibility:

All Genders

17-50 years

Brief Summary

This clinical trial will determine the outcome trajectories of common surgeries (arthroscopic Bankart repair with remplissage of a Hill-Sachs lesion, open Bankart, Latarjet) with post-operative rehabi...

Detailed Description

The objective of this study is to determine the outcome trajectories of common surgeries (arthroscopic Bankart repair with remplissage of a Hill-Sachs lesion, open Bankart, Latarjet) with post-operati...

Eligibility Criteria

Inclusion

  • Civilians and military personnel ages 17 to 50
  • Traumatic anterior shoulder dislocation
  • Associated subcritical bone loss between 10-20% less the glenoid width quantified by standard of care CT scan, MRI, or 3D-MRI scan
  • Had shoulder instability surgery using either 1) arthroscopic Bankart repair with remplissage of Hill-Sachs lesion; 2) open Bankart; or 3) Latarjet

Exclusion

  • Chronic, non-traumatic multi-directional instability based on clinical exam
  • Concurrent shoulder injury in the involved shoulder (e.g., rotator cuff tears, motor nerve pathologies, osteoarthritis of a Samilson-Prieto grade \>2)
  • Have a history of shoulder surgery in the involved shoulder (prior instability surgery that included any of the following and the planned procedure would be a repeat of the index procedure: 1) arthroscopic Bankart repair with a remplissage of Hill-Sachs lesion, 2) open Bankart, or 3) Latarjet \[previous isolated arthroscopic Bankart repair only would not be an exclusion criterion\], rotator cuff repair, intra-articular soft tissue surgery); rotator cuff repair, intra-articular soft tissue surgery)
  • Prior rotator cuff procedure on involved shoulder (including intra-articular soft tissue surgery
  • Humeral sided bone lesions (Hill-Sachs lesion) that is sufficiently large enough to render the lesion "off-track" even after a bony augmentation procedure would be performed
  • Neuromuscular, neurological and other movement control pathologies including seizures
  • Vascular injury associated with the shoulder trauma that compromise adequate/normal healing or interferes with usual course of care
  • Traumatic brain injury or any condition that would preclude the ability to comply with post-operative guidelines
  • Cartilage lesion finding in the involved shoulder that would interfere with usual course of care
  • Known pregnancy at time of imagining and/or surgery based upon standard of care testing procedures
  • Any issue with the contralateral shoulder that would preclude participation in research procedures
  • Any condition in the opinion of the investigator/clinician that would preclude or limit full participation in study activities
  • Absence of a fixed address or no means of contact
  • Known inability to be available at all follow-up time points
  • Does not plan to return to pre-injury levels of work, sports or military duty

Key Trial Info

Start Date :

January 24 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 30 2027

Estimated Enrollment :

450 Patients enrolled

Trial Details

Trial ID

NCT04809064

Start Date

January 24 2022

End Date

September 30 2027

Last Update

October 10 2025

Active Locations (15)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (15 locations)

1

Mayo Clinic

Tempe, Arizona, United States, 85288

2

Naval Medical Center

San Diego, California, United States, 92134

3

Steadman Clinic

Vail, Colorado, United States, 81657

4

University of Connecticut Health Center

Farmington, Connecticut, United States, 06030